Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Neurocognitive Changes in Chronic Hepatitis C Patients Receiving Combination Therapy of Interferon and Ribavirin: A Systematic Review
- Wani M.A. , et al.
2. Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
- Sharafi H. , et al.
3. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank
- Sharafi H. , et al.
4. Sofosbuvir and ribavirin with or without pegylated-interferon in hepatitis C virus genotype-2 or -3 infections: A systematic review and meta-analysis
- Bayatpoor M.E. , et al.
5. Hepatitis B and hepatitis C in patients with inherited disorders of hemoglobin in sistan and baluchistan province, Iran
- Khosravi S. , et al.
6. A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms
- Alavian S. , et al.
7. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
- Sharafi H. , et al.
8. The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
- Liang P.C. , et al.
9. Update on recommendations for the clinical management of hepatitis C in Iran 2017
- Alavian S.M. , et al.
10. Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C
- Keshvari M. , et al.
11. Interferon λ3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus–infected multitransfused patients with thalassemia
- Biswas A. , et al.
12. Efficacy and safety of generic sofosbuvir/ledipasvir fixed-dose combination in Iranian patients with chronic hepatitis C virus infection
- Sharafi H. , et al.
13. Assessment of hepatitis C virus RNA in peripheral blood mononuclear cells as a predictor of response to pegylated-interferon and ribavirin: A cohort study
- Miri S. , et al.
14. Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: A systematic review and meta-analysis
- Dolatimehr F. , et al.
15. The role of polymorphisms near IFNL3 gene as predictors of residual HCV RNA in buffy coat after successful antiviral therapy
- Miri S.M. , et al.
16. A simple PCR-RFLP method for genotyping of IFNL4 rs368234815 polymorphism in patients with chronic hepatitis C
- Pouryasin M. , et al.
17. Genetic variation in interleukin-28B and response to Peg-IFNα-2a/RBV combination therapy in patients with hepatitis C virus infection
- Bokharaei-Salim F. , et al.
18. Molecular tracing of hepatitis C virus genotype 1 isolates in Iran: A NS5B phylogenetic analysis with systematic review
- Hesamizadeh K. , et al.
19. Recommendations for the clinical management of hepatitis C in Iran: A consensus-based national guideline
- Alavian S.M. , et al.
20. Next steps toward eradication of hepatitis C in the era of direct acting antivirals
- Hesamizadeh K. , et al.